Vendor Intelligence Report: Peptime

Published 3 Jul 2026. 22-page investigative report on who is behind Peptime: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 10 Finnrick lab tests, Peptime records 8 pass / 2 fail, for an overall pass rate of 80%. That headline hides a sharp catalog split: Retatrutide is the buyer-positive case, with a clean current Finnrick run, while BPC-157 is the caution case, failing often enough that its current stock-out should not be read as a resolved quality issue. The full report carries the product breakdown and shows how ratings move under stricter grading.

The non-lab file is less flattering. Peptime markets American origin, US compounding, greater-than-99% purity, and a 14+ year history; public records instead show an aged domain with a recently visible peptide storefront, a newly formed Delaware legal trail, and Australian registrant and reputation signals clustered before launch. This does not disprove US dispatch, but it makes Peptime’s origin and longevity story a verification problem rather than a trust asset.

The report also traces how Peptime entered the market: launch-time amplification by a Superpower-adjacent network, a pre-launch review cluster, a peptime.link/Dub affiliate stack, and discount-code promotion with uneven disclosure. The file does not prove common ownership with Superpower-linked personnel, and it found no active copycat domains, but it does show a polished funnel where buyers need to separate batch evidence from patriotic branding and influencer incentives.

Inside the full report:

  • Appendix A laboratory data, per-product pass/fail rates, and methodology-divergence charts for both Finnrick-tested products
  • Wayback, RDAP/WHOIS, and Delaware filing analysis testing the 14+ year and American-origin claims
  • Trustpilot review-cluster analysis and reputation-timeline evidence
  • Superpower-adjacent promotion and personnel-network mapping, with ownership limits separated from documented sponsorship and amplification
  • peptime.link/Dub affiliate and discount-code trail, including disclosure-risk assessment
  • Channel-verification checklist, risk matrix, dead ends, and highest-value open leads

Risk assessment

  • Misleading history and reputation claims — high: Peptime markets 14+ years/since 2012 while records show BNT formed 2026-03-18, peptime.com parked through 2025, and early Trustpilot reviews clustered in Australia before public launch.
  • Operator-opacity and ownership-misdirection risk — high: Vendor policies name BNT Wellness Group LLC, but beneficial owners are undisclosed; RDAP lists NSW, Australia while marketing emphasizes American-owned and American-run identity.
  • BPC-157 quality-reliability concern — high: BPC-157 has 4 Finnrick tests with 2 pass / 2 fail and a 49.91% rating; current stock-out does not resolve the product record, while Retatrutide is not implicated at 6 pass / 0 fail and 85.17%.
  • Affiliate-promotion and disclosure risk — high: Dub Partners/peptime.link incentives include a 20% lifetime commission; the structured scan reproduced five promoter or owner-partner records, with referral disclosure no or unclear in several records.
  • Regulatory-association risk — medium: Evidence links Peptime’s early network to Superpower personnel; Shaun Miller’s prior employer Peptide Clinics Australia was fined A$10M, though no enforcement against Peptime or BNT was found.